封面
市场调查报告书
商品编码
1427194

全球动物模型市场规模、份额、成长分析、按类型、按应用划分 - 2023-2030 年产业预测

Global Animal Model Market Size, Share, Growth Analysis, By Type(Pigs, Cats), By Application(Research and Development, Production) - Industry Forecast 2023-2030

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年全球动物模型市场规模为22.6亿美元,从2023年的24.4亿美元增长到2031年的44.4亿美元,预测期内(2024-2031年)复合年增长率为7.8%。增长至 10,000,000 美元。

动物模型市场的目的是为研究人员提供高度可靠的模型,忠实地再现人类生理和病理。市场成长主要是由癌症、心血管疾病和神经系统疾病等慢性和复杂疾病的盛行率上升所推动的。特别是基因改造动物模型(例如基因转殖小鼠)的进步提供了非凡的机会,使研究人员能够深入研究特定基因及其在疾病进展中的作用。此外,对个人化医疗和客製化治疗的需求不断增长,为开发源自患者的动物模型和精准医疗方法提供了机会。全球动物模型市场对于科学知识的进步和药物开发具有至关重要的意义。儘管存在伦理问题和替代技术出现等挑战,该市场仍继续为了解疾病和开发新治疗方法提供重要工具。动物模型的持续技术创新和对个人化医疗日益增长的需求预示着该领域的进一步发展和进步。

使用自上而下和自下而上的方法来估计和检验动物模型的全球市场规模,并估计其他各个相关子市场的规模。用于估计市场规模的调查方法包括以下详细资讯:用于确定市场主要企业的二次研究,用于确定每个地区的市场占有率的主要和二次研究。整个过程包括研究主要企业的年度和财务报告以及广泛的采访,以获得执行长、副总裁、董事和行销负责人等行业领导者的重要见解。所有股份比率和细分均使用二手资讯确定并使用主要资讯检验。本研究涵盖的所有可能影响市场的参数都经过了考虑、详细研究、初步研究检验和分析,以获得最终的定量和定性资料。

全球动物模型市场細項分析

全球动物模型市场根据类型、应用和地区进行细分。按类型划分,市场分为猪、猫和小鼠。依用途分为研发、生产、品管。按地区划分,市场分为北美、欧洲、亚太地区、中东和非洲以及拉丁美洲。

全球动物模型市场的驱动因素

随着基因组学和精准医学的不断发展,对能够准确再现个别患者特征和治疗反应的动物模型的需求不断增长。研究人员和製药公司越来越依赖动物模型来研究特定的遗传变异并开发标靶治疗。特别是,患者来源的异种移植(PDX)模型的采用将在 2022 年获得势头,将患者肿瘤样本移植到动物宿主中进行药物测试。这些模型能够评估针对个别患者的治疗效果,有助于个人化医疗中对动物模型不断增长的需求。

基因编辑技术,尤其是CRISPR-Cas9的快速发展,已成为2022年动物模型市场的另一个关键驱动力。这些技术有助于精确操作动物模型中的基因,并能够创建与人类疾病非常相似的基因转殖模型。透过将特定的基因突变和修饰引入动物模型,研究和开发可以探索疾病的潜在机制并开发创新的治疗方法。 2022年基因编辑技术的广泛采用对于增加动物模型的使用和促进该领域的创新发挥了关键作用。

全球动物模型市场的限制因素

儘管动物模型领域取得了重大进展,但伦理问题和动物福利考量在 2022 年仍然是重要的限制因素。在研究活动中使用动物引发了伦理问题,并引发了有关动物人道待遇的争论。对动物福利法规的审查和公众的关注导致对动物模型的使用进行更严格的审查,特别是在动物福利法规严格的国家。这种伦理问题和法律规范对动物模型市场的扩张提出了挑战,并鼓励探索替代技术和模型。

2022 年市场中观察到的另一个阻碍因素是与维护动物设施、购买和饲养动物以及使用动物模型进行实验相关的高成本和复杂性。动物模型需要专用设施、专门照顾和资源,导致维修成本高。此外,与使用动物模型相关的复杂性,例如需要经验丰富的人员、遵守法规要求以及物流挑战,都会增加整体成本。这些成本和复杂性因素可能会限制动物模型的取得和使用,特别是对于预算有限的小型研究机构。

全球动物模型市场趋势

2022 年动物模型市场的一个显着趋势是越来越重视人源化和转换模型。研究人员正积极致力于创建更能反映人类生理学、疾病进展和药物反应的动物模型。这一趋势包括将人类细胞、组织和基因修饰纳入动物模型中,以增加其与人类疾病的相关性。例如,开发具有人类免疫系统的人源化小鼠将使免疫相关疾病的更精确研究和免疫疗法测试成为可能。 2022 年人源化和转化模型的转变凸显了该产业对提高动物模型在人类疾病研究中的可预测性和适用性的承诺。

目录

  • 执行摘要
  • 调查方法
  • 母市场分析
  • 主要市场考察
    • 技术分析
    • 价格分析
    • 供应链分析
    • 价值链分析
    • 市场生态系统
    • 智慧财产权分析
    • 贸易分析
    • Start-Ups分析
    • 原料分析
    • 创新矩阵
    • 研发线产品分析
    • 总体经济指标
    • 主要投资分析
    • 关键成功因素
    • 竞争程度
  • 市场动态及展望
    • 市场动态
      • 促进因素
      • 机会
      • 抑制因素
      • 任务
    • 监管形势
    • 波特的分析
    • 对未来中断的特殊考虑
  • 全球动物模型市场:按类型
    • 市场概况
    • 小鼠或大鼠
  • 全球动物模型市场:依应用分类
    • 市场概况
    • 研究与开发
    • 生产
    • 品管
  • 全球动物模型市场规模:按地区划分
    • 市场概况
    • 北美洲
      • 美国
      • 加拿大
    • 欧洲
      • 德国
      • 西班牙
      • 法国
      • 英国
      • 其他欧洲国家地区
    • 亚太地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 其他亚太地区
    • 拉丁美洲
      • 巴西
      • 其他拉丁美洲地区
    • 中东和非洲 (MEA)
      • 海湾合作委员会国家
      • 南非
      • 其他中东/非洲地区
  • 竞争形势
    • 前5名企业对比
    • 主要企业市场定位(2021年)
    • 主要市场参与者所采取的策略
    • 关键成功策略
    • 近期市集活动
    • 主要企业市场占有率(2021年)
  • 主要企业简介
    • Charles River Laboratories International Inc.(US)
    • Envigo(US)
    • The Jackson Laboratory(US)
    • Taconic Biosciences Inc.(US)
    • genOway SA(France)
    • Horizon Discovery Group plc(UK)
    • TransGenic Inc.(Japan)
    • Crown Bioscience Inc.(US)
    • Janvier Labs(France)
    • Laboratory Corporation of America Holdings(US)
    • Harbour Antibodies BV(Netherlands)
    • Eurofins Scientific(Luxembourg)
    • Biocytogen LLC(US)
    • Transnetyx Inc.(US)
    • Ingenious Targeting Laboratory(US)
    • Charles River Japan(Japan)
    • Cyagen Biosciences Inc.(US)
    • Ozgene Pty Ltd(Australia)
    • Hera Biolabs Inc.(US)
    • Pharmaron Beijing Co., Ltd.(China)
简介目录
Product Code: SQMIG35A2418

Global Animal Model Market size was valued at USD 2.26 Billion in 2022 and is poised to grow from USD 2.44 Billion in 2023 to USD 4.44 Billion by 2031, at a CAGR of 7.8% during the forecast period (2024-2031).

The animal model market serves the purpose of furnishing researchers with dependable models that closely emulate human physiology and pathophysiology. The market's growth is primarily driven by the escalating prevalence of chronic and intricate diseases like cancer, cardiovascular disorders, and neurological conditions. It presents notable opportunities, particularly with the advancement of genetically modified animal models like transgenic mice, enabling researchers to delve into specific genes and their roles in disease progression. Furthermore, the increasing demand for personalized medicine and tailored therapies creates avenues for developing patient-derived animal models and precision medicine approaches. The global animal model market holds pivotal significance in advancing scientific knowledge and drug development. Despite encountering challenges such as ethical concerns and the emergence of alternative technologies, the market persists in offering indispensable tools for comprehending diseases and devising new treatments. The continual innovation in animal models and the surging demand for personalized medicine augur well for further growth and progress in this domain.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Animal Model Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Animal Model Market Segmental Analysis

The global animal model market is segmented on the basis of type, application, and region. Based on type, the market is segmented into pigs, cats, and mice. By Application, the market is segmented into research and development, production, and quality control. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Animal Model Market

As genomics and precision medicine continue to advance, there is a growing demand for animal models that can accurately replicate individual patient characteristics and responses to treatments. Researchers and pharmaceutical companies are increasingly relying on animal models to investigate specific genetic variations and develop targeted therapies. Notably, the adoption of patient-derived xenograft (PDX) models gained momentum in 2022, where animal hosts are implanted with patient tumour samples for drug testing. These models enable the assessment of treatment efficacy tailored to individual patients, contributing to the heightened demand for animal models in personalized medicine.

The rapid progress of gene editing technologies, particularly CRISPR-Cas9, emerged as another significant driver in the 2022 animal model market. These technologies facilitate precise manipulation of genes in animal models, allowing the creation of genetically modified models that closely resemble human diseases. Researchers can introduce specific genetic mutations or modifications in animal models to explore the underlying mechanisms of diseases and develop innovative therapeutics. The widespread adoption of gene editing technologies in 2022 played a pivotal role in increasing the utilization of animal models and fostering innovation in the field.

Restraints in the Global Animal Model Market

Despite notable advancements in the field of animal models, ethical concerns and considerations for animal welfare remained significant constraints in 2022. The use of animals in research activities raises ethical questions and triggers debates regarding the humane treatment of animals. The scrutiny of animal welfare regulations and public attention has led to increased oversight of the use of animal models, especially in countries with stringent regulations pertaining to animal welfare. These ethical concerns and regulatory frameworks pose challenges to the expansion of the animal model market and incentivize the exploration of alternative technologies and models.

Another impediment observed in the market in 2022 was the high costs and complexities associated with maintaining animal facilities, procuring and breeding animals, and conducting experiments using animal models. Animal models demand dedicated facilities, specialized care, and resources, contributing to their substantial maintenance costs. Furthermore, the intricacies associated with working with animal models, such as the need for experienced personnel, adherence to regulatory requirements, and logistical challenges, amplify the overall expenses. These cost and complexity factors can restrict the accessibility and utilization of animal models, particularly for smaller research organizations operating with limited budgets.

Market Trends of the Global Animal Model Market

A notable trend observed in the 2022 animal model market was the growing emphasis on humanized and translational models. Researchers are actively working to create animal models that closely mirror human physiology, disease progression, and responses to drugs. This trend involves the integration of human cells, tissues, or genetic modifications into animal models to enhance their relevance to human diseases. For instance, the development of humanized mice with a human immune system allows for more accurate studies of immune-related diseases and testing of immunotherapies. The shift towards humanized and translational models in 2022 underscores the industry's commitment to enhancing the predictability and applicability of animal models in human disease research.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
    • Regulatory Landscape
    • Porters Analysis
      • Competitive rivalry
      • Threat of Substitute Products
      • Bargaining Power of Buyers
      • Threat of New Entrants
      • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
      • Political Impact
      • Economic Impact
      • Social Impact
      • Technical Impact
      • Environmental Impact
      • Legal Impact
  • Global Animal Model Market by Type
    • Market Overview
    • Pigs
    • Cats
    • and Mice
  • Global Animal Model Market by Application
    • Market Overview
    • Research and Development
    • Production
    • and Quality Control
  • Global Animal Model Market Size by Region
    • Market Overview
    • North America
      • USA
      • Canada
    • Europe
      • Germany
      • Spain
      • France
      • UK
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia-Pacific
    • Latin America
      • Brazil
      • Rest of Latin America
    • Middle East & Africa (MEA)
      • GCC Countries
      • South Africa
      • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
      • By Development
      • By Company
      • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Charles River Laboratories International Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Envigo (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • The Jackson Laboratory (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Taconic Biosciences Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • genOway SA (France)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Horizon Discovery Group plc (UK)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • TransGenic Inc. (Japan)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Crown Bioscience Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Janvier Labs (France)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Laboratory Corporation of America Holdings (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Harbour Antibodies BV (Netherlands)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Eurofins Scientific (Luxembourg)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Biocytogen LLC (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Transnetyx Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Ingenious Targeting Laboratory (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Charles River Japan (Japan)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Cyagen Biosciences Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Ozgene Pty Ltd (Australia)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Hera Biolabs Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Pharmaron Beijing Co., Ltd. (China)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments